Simplify Your Laboratory Experience

Gold Standard Diagnostics, LLC. is a leading healthcare provider of diagnostic solutions with extensive experience in the clinical market. Our comprehensive diagnostic offering includes an innovative suite of automated platforms and a broad menu of assays, completed with outstanding customer service. We aim to provide solutions that improve lab efficiency and minimize overall costs.

We are fully committed to enhancing patient care by dedicating our efforts to product development, quality manufacturing, and global commercialization of diagnostic solutions. Through an extensive product menu and outstanding customer service, we solve real laboratory problems.

New Release from Gold Standard Diagnostics!

Gold Standard Diagnostics is pleased to announce the release of the AIX1000® 2.1!

Among other benefits, this update ensures the processing, analysis, and results interpretation for RPR screens and titers out to 1:2048.

Reach out to your Gold Standard Diagnostics Representative for more details on this exciting new update!

Latest News

2/6/2024
Improved Lyme Screening Assay Now FDA Cleared for Laboratory Use
Gold Standard Diagnostics (GSD) today announced it offers a new B. burgdorferi VlsE-OspC IgG/IgM recombinant ELISA Screen that can be used to improve workflow and conserve testing resources. This assay has demonstrated increased sensitivity for early Lyme Disease detection - up to 20% over existing available Lyme screening assays - while maintaining 98% specificity. True Lyme negative samples are eliminated prior to second-tier testing.
Read more »
11/30/2023
MEDICA 2023: Unveiling Success in Dusseldorf!
From November 13th to 16th, 2023, we attended the MEDICA trade show in Dusseldorf and this time, was extra special. The star of the show was undeniably the unveiling of Hurricane Dx, our new CLIA product line for autoimmune and infectious disease testing.
Read more »